ZIOPHARM, Inc. Seeks Lower Cancer Drug Prices
Published: Jun 02, 2011
Recent advances in cancer treatment typically come with eye-popping price tags for therapies that may offer only a few months of extra life. For example, Bristol-Myers Squibb Co's Yervoy for advanced melanoma runs $120,000 for a four-infusion course of treatment. Dendreon Corp's Provenge for advanced prostate cancer costs about $93,000.